Before the rise of GLP-1 medications, earlier prescription weight loss drugs offered limited effectiveness and often carried serious side effects
The interplay between Semaglutide-induced weight loss and thyroid hormone replacement therapy a cornerstone in the management of Hashimotosraises pertinent questions regarding dosage adjustments, metabolic effects, and overall thyroid stability
This selectivity is crucial, as many other GH secretagogues also stimulate the release of ACTH and cortisol, which can lead to unwanted side effects
It is therefore often seen in women aged 20 to 70 (the population most often affected with constipation), but its development does not depend on age or duration of constipation
Like tirzepatide, semaglutide hasnt been studied much in breastfeeding moms
I was doing what I had to do.